Imuldosa 45 mg/0,5 ml, Injektionslösung in einer Fertigspritze

7680702240015 CH-70224 Injektionslösung

Associated product:

IMULDOSA 45 mg/0,5 ml sol inj ser prérempl 45 mg 1

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/04/2026
Patient information leaflet
Français
29/04/2026
Patient information leaflet
Italien
29/04/2026
Summary of Product Characteristics
Allemand
29/04/2026
Summary of Product Characteristics
Français
29/04/2026
Summary of Product Characteristics
Italien
29/04/2026

Detailed composition

Substance Quantity Type Category
ustekinumabum
45.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 1252.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2026

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
70224
Drug name
Imuldosa, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AC05
Authorization status
Z
Dispensing category
B
First authorization
14/11/2025
Authorization expiration date
13/11/2030
IT Number
07.15.0.
Domain
Human medicine
Field of application
Plaque-Psoriasis ab 6 Jahren, Psoriasis-Arthritis, Morbus Crohn, Ulcerative Colitis

Package details

Description (FR)
IMULDOSA 45 mg/0,5 ml sol inj ser prérempl 45 mg 1
Description (DE)
IMULDOSA 45 mg/0,5 ml Inj Lös Fertigspr 45 mg 1 St
Market launch
29/04/2026
Narcotic (BTM)
No

Other package sizes (1)

IMULDOSA 90 mg/1,0 ml sol inj ser prérempl 90 mg 1
1 FESP
GTIN: 7680702240022
View
Buy us a coffee Explore the data